Feb 20 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL
RESULTS
* Q4 EARNINGS PER SHARE $0.28
* SEES FY 2020 REVENUE $160 MILLION TO $165 MILLION
* Q4 REVENUE $29.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$27.6
MILLION
* Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.43 EXCLUDING
ITEMS
* Q4 EARNINGS PER SHARE ESTIMATE $0.42 -- REFINITIV IBES
DATA
* ANIKA THERAPEUTICS - TOTAL REVENUE FOR Q4 OF 2019
INCREASED 10%
YEAR-OVER-YEAR TO $29.8 MILLION, COMPARED TO $27.0 MILLION FOR
Q4 OF 2018
* ANIKA THERAPEUTICS - CO EXPECTS TOTAL REVENUE TO BE IN
RANGE OF
$160 MILLION TO $165 MILLION FOR THE FULL YEAR OF 2020
* ANIKA THERAPEUTICS - CAPITAL EXPENDITURES ARE EXPECTED TO
BE
BETWEEN $5 MILLION AND $7 MILLION FOR 2020
Source text for Eikon: ID:nGNX4ctPR3
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))